期刊文献+

CT引导下注射臭氧治疗椎间盘源性腰痛的临床研究 被引量:4

Clinical study of treatment of discogenic low back pain with CT guided ozone injection
原文传递
导出
摘要 目的探讨椎间盘内注射臭氧对椎间盘源性腰痛的疗效。方法 2005年5月至2009年7月,72例椎间盘源性腰痛患者行CT引导下椎间盘内注射臭氧治疗,质量浓度为30~40μg/mL,剂量为5~10mL,疼痛复制反应阳性66例(91.67%)。结果随访7~54个月,平均20个月,腰痛及下肢痛症状明显缓解,均恢复正常生活。VAS评分较术前下降50.36±2.32(P<0.01),ODI评分下降42.23±5.38(P<0.01)。优良率90.28%(65/72),有效率100%。所有患者均未发生椎间隙感染、神经根损伤、臭氧气栓等并发症。结论 CT引导下椎间盘内注射臭氧治疗椎间盘源性腰痛是一种安全有效的方法。注射臭氧的CT表现近似椎间盘造影。 Objective To explore the effectiveness of the intervertebral disc ozone therapy for discogenic low back pain.Methods From May 2005 to July 2009,72 patients with discogenic low back pain were treated with CT-guided intervertebral disc ozone injection,of which the concentration and dosage were 30-40 ug/ml and 5-10 mL,respectively.66 cases(91.67%)showed positive pain reproduction.Results All cases were followed up for an average period of 20 months(range from 7 to 54 months).All patients recovered well and returned to their normal lives.Compared with the pre-operative period,the average decrease of VAS scoring and ODI scoring were 50.36 ± 2.32(P〈0.01)and 42.23±5.38(P〈0.01),respectively.The success rate was 90.28%(65/72)and the effective rate was 100%.There was no infection,nerve root injury,or ozone embolism.Conclusion Treatment of discogenic low back pain with CT-guided ozone injection is a safe and effective apporach.CT manifestation of ozone injection is similar to Discography.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第12期108-112,共5页 Journal of Shandong University:Health Sciences
关键词 椎间盘源性腰痛 臭氧 CT引导 疗效 Discogenic low back pain; Ozone; CT guided; Curative effect;
  • 相关文献

参考文献10

二级参考文献99

共引文献785

同被引文献34

  • 1宁方林.臭氧注射治疗腰椎间盘突出症[J].中华临床医师杂志(电子版),2011,5(11):3360-3362. 被引量:4
  • 2侯健,姜华.双膦酸盐类药物治疗多发性骨髓瘤骨病的评价[J].中国医院用药评价与分析,2005,5(3):138-141. 被引量:3
  • 3阮狄克.椎间盘源性腰痛[J].中华骨科杂志,2007,27(3):161-161. 被引量:16
  • 4夏群,Steffen Sola,胡永成,苗军,张继东,李建光,马毅,张晓林,周静.椎间盘源性腰痛的诊断与治疗初步报告[J].中华骨科杂志,2007,27(3):162-166. 被引量:57
  • 5Brown J E, Coleman R E. The role of bisphosphonates in breast cancer: the present and future role of bisphosphonates in the management of patients with breast cancer [J]. Breast Cancer Res, 2002,4( 1 ) :24-29.
  • 6Rogers M J, Gordon S, Benford H L, et al. Cellular and molecular mechanisms of action of bisphosphonates [J]. Cancer, 2000, 88(12) :2961-2978.
  • 7Suzuki K, Takeyama S, Kikuchi T, et al. Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy [J]. J Histochem Cytochem, 2005, 53 (12) : 1525-1537.
  • 8Ito M, Amizuka N, Nakajima T, et al. Ultrastructural and cytochemical studies on cell death of osteoclasts in- duced by bisphosphonate treatment [J]. Bone, 1999, 25 (4) :447-452.
  • 9Marx R E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic[J]. J Oral Maxillofac Surg, 2003, 61 (9): 1115-1117.
  • 10Khosla S, Burr D, Cauley J, et al. American Society for Bone and Mineral Research [J]. J Bone Miner Res, 2007, 22(10) :1479-1491.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部